Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine

European Journal of Pharmacology

Volumn 354, Issue 1, 1998, Pages 9-16

  Arnold, Jonathon C ^a   Topple, Ann N ^a   Hunt, Glenn E ^a   McGregor, Lain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cannabinoid; Cocaine; CP 55,940; Locomotor activity; Polydrug abuse; Sensitization

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; COCAINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CYCLOHEXANOLS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; MALE; RATS; RATS, INBRED LEW; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SENSITIVITY AND SPECIFICITY;

EID: 0031691194     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00433-6     Document Type: Article

References (39)

1. Bonate, P.L., Swann, A., Silverman, P.B., 1997. Context-dependent cross-sensitization between cocaine and amphetamine. Life Sci. 60, 1-7.
2. Camp, D.M., Browman, K.E., Robinson, T.E., 1994. The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats. Brain Res. 668, 180-193.
3. Chaperon, F., Soubrie, P., Puech, A.J., Thiebot, M.H., 1998. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology 135, 324-332.
4. Cunningham, S.T., Finn, M., Kelley, A.E., 1997. Sensitization of the locomotor response to psychostimulants after repeated opiate exposure: role of the nucleus accumbens. Neuropsychopharmacology 16, 147-155.
5. Gardner, E.L., Lowinson, J.H., 1991. Marijuana's interaction with brain reward systems: update 1991. Pharmacol. Biochem. Behav. 40, 571-580.
6. Gold, L.H., Balster, R.L., Barrett, R.L., Britt, D.T., Martin, B.R., 1992. A comparison of the discriminative stimulus properties of delta 9-tetra-hydrocannabinol and CP 55,940 in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 262, 479-486.
7. Greenberg, B.D., Segal, D.S., 1985. Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors. Pharmacol. Biochem. Behav. 23, 99-105.
8. Hall, W.D., Carless, J.M., Haines, P.J., Flaherty, B.J., Reilly, C.J., 1991. The characteristics of cocaine users among young adults living in Sydney. Med. J. Aust. 155, 11-14.
9. Haracz, J.L., MacDonall, J.S., Sircar, R., 1997. Effects of nitric oxide synthase inhibitors on cocaine sensitization. Brain Res. 746, 183-189.
10. Hoffman, D.C., Wise, R.A., 1992. Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections. Psychopharmacology 107, 277-284.
11. Hoffman, D.C., Wise, R.A., 1993. Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin. Psychopharmacology 110, 402-408.
12. Itzhak, Y., 1997. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J. Pharmacol. Exp. Ther. 282, 521-527.
13. Jodogne, C., Marinelli, M., Le Moal, M., Piazza, P.V., 1994. Animals predisposed to develop amphetamine self-administration show higher susceptibility to develop contextual conditioning of both amphetamine-induced hyperlocomotion and sensitization. Brain Res. 657, 236-244.
14. Kalivas, P.W., Alesdatter, J.E., 1993. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267, 486-495.
15. Kalivas, P.W., Duffy, P., 1989. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol. Psychiatry 25, 913-928.
16. Kalivas, P.W., Weber, B., 1988. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245, 1095-1102.
17. Keppel, G., 1991. Design and Analysis: A Researcher's Handbook, Prentice-Hall, Englewood Cliffs, NJ.
18. Kosten, T.A., Miserendino, M.J., Chi, S., Nestler, E.J., 1994. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J. Pharmacol. Exp. Ther. 269, 137-144.
19. Lepore, M., Liu, X.H., Savage, V., Matalon, D., Gardner, E.L., 1996. Genetic differences in delta(9)-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci. 58, 365-372.
20. Lett, B.T., 1989. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology 98, 357-362.
21. Little, P.J., Compton, D.R., Johnson, M.R., Melvin, L.S., Martin, B.R., 1988. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J. Pharmacol. Exp. Ther. 247, 1046-1051.
22. Mattingly, B.A., Fields, S.E., Langfels, M.S., Rowlett, J.K., Robinet, P.M., Bardo, M.T., 1996a. Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine. Psychopharmacology 125, 33-42.
23. Mattingly, B.A., Rowlett, J.K., Ellison, T., Rase, K., 1996b. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacol. Biochem. Behav. 53, 481-486.
24. McGregor, I.S., 1996. Using Strawberry Tree WorkbenchMac and Work-bench PC software for data acquisition and control in the animal learning laboratory. Behav. Res. Methods Instrum. Comput. 28, 38-48.
25. McGregor, I.S., Bryant, P.A., Arnold, J.C., 1995. CP 55,940, a synthetic cannabinoid, dose not sensitize locomotor activity or cocaine responsivity with intermittent administration in Wistar rats. Soc. Neurosci. Abstr. 21, 726.
26. McGregor, I.S., Issakidis, C.N., Prior, G., 1996. Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacol. Biochem. Behav. 53, 657-664.
27. McGregor, I.S., Arnold, J.C., Weber, M.F., Topple, A.N., Hunt, G.E., 1998. A comparison of Δ9-THC and anandamide induced c-fos expression in the rat forebrain. Brain Res., in press.
28. Miller, N.S., Klahr, A.L., Gold, M.S., Sweeney, K., Cocores, J.A., Sweeney, D.R., 1990. Cannabis diagnosis of patients receiving treatment for cocaine dependence. J. Subst. Abuse 2, 107-111.
29. Ortiz, J., DeCaprio, J.L., Kosten, T.A., Nestler, E.J., 1995. Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience 67, 383-397.
30. Parker, L.A., Gillies, T., 1995. THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav. Neurosci. 109, 71-78.
31. Robinson, T.E., Berridge, K.C., 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291.
32. Rowlett, J.K., Mattingly, B.A., Bardo, M.T., 1995. Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists. Synapse 20, 209-216.
33. Stewart, J., Badiani, A., 1993. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4, 289-312.
34. Swift, W., Hall, W., Copeland, J., 1997. Pattern and correlates of cannabis dependence among long term users in Sydney, Australia, NDARC Technical Monograph, Sydney.
35. Tanda, G., Pontieri, F.E., DI Chiara, G., 1997. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism. Science 276, 2048-2050.
36. Vezina, P., Stewart, J., 1990. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 516, 99-106.
37. Vezina, P., Giovino, A.A., Wise, R.A., Stewart, J., 1989. Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol. Biochem. Behav. 32, 581-584.
38. Wiley, J.L., Barrett, R.L., Lowe, J., Balster, R.L., Martin, B.R., 1995. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34, 669-676.
39. Wolf, M.E., Jeziorski, M., 1993. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613, 291-294.